BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $229,000 | -15.2% | 4,248 | -7.8% | 0.02% | -8.7% |
| Q2 2022 | $270,000 | -31.8% | 4,605 | -9.8% | 0.02% | -32.4% |
| Q1 2022 | $396,000 | -4.3% | 5,106 | +6.0% | 0.03% | -5.6% |
| Q4 2021 | $414,000 | +12.8% | 4,819 | +5.7% | 0.04% | 0.0% |
| Q3 2021 | $367,000 | +4.6% | 4,558 | +4.4% | 0.04% | +2.9% |
| Q2 2021 | $351,000 | -1.1% | 4,366 | +3.8% | 0.04% | 0.0% |
| Q1 2021 | $355,000 | +3.2% | 4,207 | -1.8% | 0.04% | 0.0% |
| Q4 2020 | $344,000 | -12.5% | 4,284 | -12.4% | 0.04% | -20.5% |
| Q3 2020 | $393,000 | -8.6% | 4,892 | -2.1% | 0.04% | -13.7% |
| Q2 2020 | $430,000 | +15.0% | 4,998 | +8.4% | 0.05% | +41.7% |
| Q1 2020 | $374,000 | -12.2% | 4,609 | -9.6% | 0.04% | -36.8% |
| Q4 2019 | $426,000 | -13.8% | 5,100 | -9.7% | 0.06% | -10.9% |
| Q3 2019 | $494,000 | +14.1% | 5,645 | +6.9% | 0.06% | +16.4% |
| Q2 2019 | $433,000 | +8.8% | 5,282 | +8.0% | 0.06% | +17.0% |
| Q1 2019 | $398,000 | +21.7% | 4,891 | -1.6% | 0.05% | +11.9% |
| Q4 2018 | $327,000 | -24.8% | 4,972 | -11.9% | 0.04% | -16.0% |
| Q3 2018 | $435,000 | +5.3% | 5,642 | +0.8% | 0.05% | -3.8% |
| Q2 2018 | $413,000 | +21.5% | 5,597 | +7.0% | 0.05% | +15.6% |
| Q1 2018 | $340,000 | -3.7% | 5,230 | -4.3% | 0.04% | -4.3% |
| Q4 2017 | $353,000 | +20.1% | 5,464 | +16.5% | 0.05% | +56.7% |
| Q3 2017 | $294,000 | +5.8% | 4,690 | +2.2% | 0.03% | 0.0% |
| Q2 2017 | $278,000 | -2.5% | 4,589 | -16.4% | 0.03% | -9.1% |
| Q1 2017 | $285,000 | +25.6% | 5,492 | +7.4% | 0.03% | +6.5% |
| Q4 2016 | $227,000 | -5.4% | 5,112 | +1.2% | 0.03% | +14.8% |
| Q3 2016 | $240,000 | +22.4% | 5,050 | +16.5% | 0.03% | +22.7% |
| Q2 2016 | $196,000 | +12.0% | 4,333 | +1.9% | 0.02% | -43.6% |
| Q1 2016 | $175,000 | -50.6% | 4,252 | -16.1% | 0.04% | -58.1% |
| Q2 2015 | $354,000 | -0.6% | 5,066 | -2.5% | 0.09% | -11.4% |
| Q1 2015 | $356,000 | +19.5% | 5,195 | +27.9% | 0.10% | -6.2% |
| Q4 2014 | $298,000 | +16.0% | 4,062 | +13.5% | 0.11% | +5.7% |
| Q3 2014 | $257,000 | +26.0% | 3,578 | +26.8% | 0.11% | +14.0% |
| Q2 2014 | $204,000 | – | 2,821 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |